Paraventricular Hypothalamic Nucleus
"Paraventricular Hypothalamic Nucleus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Nucleus in the anterior part of the HYPOTHALAMUS.
Descriptor ID |
D010286
|
MeSH Number(s) |
A08.186.211.464.497.342.400 A08.186.211.730.317.357.342.400
|
Concept/Terms |
Paraventricular Hypothalamic Nucleus- Paraventricular Hypothalamic Nucleus
- Hypothalamic Nucleus, Paraventricular
- Nucleus, Paraventricular Hypothalamic
- Paraventricular Nucleus
- Nucleus, Paraventricular
- Hypothalamic Paraventricular Nucleus
- Nucleus, Hypothalamic Paraventricular
- Paraventricular Nucleus, Hypothalamic
|
Below are MeSH descriptors whose meaning is more general than "Paraventricular Hypothalamic Nucleus".
Below are MeSH descriptors whose meaning is more specific than "Paraventricular Hypothalamic Nucleus".
This graph shows the total number of publications written about "Paraventricular Hypothalamic Nucleus" by people in this website by year, and whether "Paraventricular Hypothalamic Nucleus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 0 | 1 | 1 |
2001 | 0 | 1 | 1 |
2002 | 0 | 2 | 2 |
2008 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Paraventricular Hypothalamic Nucleus" by people in Profiles.
-
Superoxide anions mediate the effects of angiotensin (1-7) analog, alamandine, on blood pressure and sympathetic activity in the paraventricular nucleus. Peptides. 2019 08; 118:170101.
-
Control of food intake and energy expenditure by Nos1 neurons of the paraventricular hypothalamus. J Neurosci. 2014 Nov 12; 34(46):15306-18.
-
Differential effects of refeeding on melanocortin-responsive neurons in the hypothalamic paraventricular nucleus. Endocrinology. 2008 Sep; 149(9):4329-35.
-
Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis. Endocrinology. 2002 Dec; 143(12):4513-9.
-
Agouti-related protein (AGRP) has a central inhibitory action on the hypothalamic-pituitary-thyroid (HPT) axis; comparisons between the effect of AGRP and neuropeptide Y on energy homeostasis and the HPT axis. Endocrinology. 2002 Oct; 143(10):3846-53.
-
5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells. J Neurosci. 2001 May 15; 21(10):3572-9.
-
p-Chlorophenylalanine and fluoxetine inhibit D-fenfluramine-induced Fos expression in the paraventricular nucleus, cingulate cortex and frontal cortex but not in other forebrain and brainstem regions. Brain Res. 1997 Nov 07; 774(1-2):94-105.
-
Differential regulation of corticotropin-releasing hormone mRNA in rat brain. Am J Physiol. 1990 Apr; 258(4 Pt 1):E686-92.